Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 11/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.58 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.58 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.58 |
| ▸ | S1PR1 | P21453 | 4/20 | 0.57 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.57 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 2/20 | 0.56 |
| ▸ | PPARD | Q03181 | 1/20 | 0.56 |
| ▸ | PPARA | Q07869 | 1/20 | 0.56 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4530820 | 0.87 | FFAR1 (0.88) | FFAR1LMNAL3MBTL1FFAR4S1PR1 | |
| SCHEMBL4656572 | 0.86 | FFAR1 (0.97) | FFAR1LMNAL3MBTL1FFAR4S1PR1 | |
| SCHEMBL6497674 | 0.86 | LMNA (0.79) | FFAR1LMNAL3MBTL1FFAR4S1PR1 | |
| SCHEMBL2183912 | 0.86 | LMNA (0.79) | FFAR1LMNAL3MBTL1FFAR4S1PR1 | |
| SCHEMBL17320238 | 0.86 | LMNA (0.79) | FFAR1LMNAL3MBTL1FFAR4S1PR1 | |
| SCHEMBL3488457 | 0.86 | LMNA (0.79) | FFAR1LMNAL3MBTL1FFAR4S1PR1 | |
| SCHEMBL8378949 | 0.86 | LMNA (0.79) | FFAR1LMNAL3MBTL1FFAR4S1PR1 | |
| SCHEMBL8558255 | 0.86 | LMNA (0.79) | FFAR1LMNAL3MBTL1FFAR4S1PR1 | |
| SCHEMBL2185137 | 0.86 | LMNA (0.79) | FFAR1LMNAL3MBTL1FFAR4S1PR1 | |
| SCHEMBL6496565 | 0.86 | LMNA (0.79) | FFAR1LMNAL3MBTL1FFAR4S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE42221-E1 | Polymerizable liquid crystal composition and polymer thereof | CHISSO CORPORATION (JP) | 2011-03-15 | — | — | US | disclosed |
| US-7393569-B2 | Hexafluoroisopropylidenebis- and sulfonylbis-(phenoxycarbonylphenoxyalkyl acrylates); hexafluoroisopropylidenebis- and sulfonylbis-(phenoxycarbonylphenoxyalkyloxetanes; stabilizes polymerizable liquid crystal compositions for a long time and controls the alignment of liquid crystal molecules | CHISSO CORPORATION (JP) | 2008-07-01 | — | — | US | disclosed |
| US-7378135-B2 | Polymerizable liquid crystal composition and optically anisotropic thin film | CHISSO CORPORATION (JP) | 2008-05-27 | — | — | US | disclosed |
| US-20060278851-A1 | Polymerizable liquid crystal composition and polymer thereof | CHISSO CORPORATION AND CHISSO PETROCHEMICAL CORPORATION | 2006-12-14 | — | — | US | disclosed |
| US-20060222784-A1 | Polymerizable liquid crystal composition and optically anisotropic thin film | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2006-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060278851-A1 | Polymerizable liquid crystal composition and polymer thereof | NCAPD2, LANCL2, TAF1 | FFAR1 659/4885LMNA 2785/4885L3MBTL1 1196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.